SpliceBio
Biotechnology company exploiting protein splicing to develop next generation gene therapies
SpliceBio has raised €168M across 2 funding rounds from 9 investors, most recently a Series B round in Jun 2025. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainsplice.bio ↗
Total raised
€168M
€168,079,244
Funding rounds
2
Investors
9
distinct backers
Active since
2022-02
latest 2025-06
Funding by year
EUR raised per yearSpliceBio — funding by year — interactive chart.
Data table
| SpliceBio — funding by year | |
|---|---|
| 2022 | €50M |
| 2025 | €118M |
Signals
High confidenceRaise-next likelihood77
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood23
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-11 | Series B | €118M | Asabys Partners,EQT Life Sciences,Gilde Healthcare,New Enterprise Associates,Novartis Venture Fund,Roche Venture Fund+3 more | View deal → |
| 2022-02-16 | Series A | €50M | Asabys Partners,Gilde Healthcare,New Enterprise Associates,Novartis Venture Fund,UCB Ventures,Ysios Capital | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData